Published in Leuk Res on July 23, 2011
Regulation of NMDA receptor trafficking by amyloid-beta. Nat Neurosci (2005) 9.17
Dissecting the genomic complexity underlying medulloblastoma. Nature (2012) 4.77
The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugs. J Immunol (2003) 3.09
The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss. Nat Immunol (2012) 2.48
A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J (2007) 2.44
Vitamin B(12)-responsive pancytopenia mimicking myelodysplastic syndrome. Acta Haematol (2011) 2.18
Acute myeloid leukemia associated with FGFR1 abnormalities. Int J Hematol (2013) 2.12
Complement-mediated inhibition of neovascularization reveals a point of convergence between innate immunity and angiogenesis. Blood (2010) 2.08
Risk-adapted preemptive therapy for cytomegalovirus disease after allogeneic stem cell transplantation: a single-center experience in Korea. Int J Hematol (2005) 2.00
Previous best responses can be re-achieved by resumption after imatinib discontinuation in patients with chronic myeloid leukemia: implication for intermittent imatinib therapy. Leuk Lymphoma (2009) 1.86
Platelets contribute to the pathogenesis of experimental autoimmune encephalomyelitis. Circ Res (2012) 1.85
Selective abrogation of the uPA-uPAR interaction in vivo reveals a novel role in suppression of fibrin-associated inflammation. Blood (2010) 1.82
Palladium-catalyzed ring-forming aminoacetoxylation of alkenes. J Am Chem Soc (2005) 1.82
Structural and functional insights into the B30.2/SPRY domain. EMBO J (2006) 1.82
FAM20: an evolutionarily conserved family of secreted proteins expressed in hematopoietic cells. BMC Genomics (2005) 1.70
Outcomes of pulmonary valve replacement in 170 patients with chronic pulmonary regurgitation after relief of right ventricular outflow tract obstruction: implications for optimal timing of pulmonary valve replacement. J Am Coll Cardiol (2012) 1.69
Intact-protein-based high-resolution three-dimensional quantitative analysis system for proteome profiling of biological fluids. Mol Cell Proteomics (2005) 1.59
The neutrophil-specific antigen CD177 is a counter-receptor for platelet endothelial cell adhesion molecule-1 (CD31). J Biol Chem (2007) 1.53
Permanent epicardial pacing in pediatric patients: 12-year experience at a single center. Ann Thorac Surg (2011) 1.52
Bone scan images reveal increased osteoblastic function after bortezomib treatment in patients with multiple myeloma. Eur J Haematol (2010) 1.49
Histone H2AX is integral to hypoxia-driven neovascularization. Nat Med (2009) 1.48
Is use of PPIs related to increased intraepithelial lymphocytes in the colon? Dig Dis Sci (2012) 1.45
Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas. Neurosurgery (2008) 1.44
Azacitidine Pre-Treatment Followed by Reduced-Intensity Stem Cell Transplantation in Patients with Higher-Risk Myelodysplastic Syndrome. Acta Haematol (2015) 1.42
Equivalent outcome of autologous stem cell transplantation and reduced intensity conditioning stem cell transplantation in acute myeloid leukemia patients with t(8;21). Acta Haematol (2014) 1.40
Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor [corrected]. J Immunol (2003) 1.38
The immunogenomics of minor histocompatibility antigens. Immunol Rev (2002) 1.32
Tumor targeting and imaging using cyclic RGD-PEGylated gold nanoparticle probes with directly conjugated iodine-125. Small (2011) 1.23
Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation. Transplantation (2010) 1.23
Novel aspects in the regulation of the leukocyte adhesion cascade. Thromb Haemost (2009) 1.11
Total synthesis of kendomycin: a macro-C-glycosidation approach. J Am Chem Soc (2004) 1.10
A retest of two HIV disclosure theories: the women's story. Health Soc Work (2008) 1.07
The immunomodulatory action of sialostatin L on dendritic cells reveals its potential to interfere with autoimmunity. J Immunol (2009) 1.05
Cotransplantation of marrow stromal cells may prevent lethal graft-versus-host disease in major histocompatibility complex mismatched murine hematopoietic stem cell transplantation. Int J Hematol (2004) 1.01
Allele frequencies of 15 STR loci using AmpF/STR Identifiler kit in a Korean population. Forensic Sci Int (2003) 1.01
Clinical manifestations of CNS infections caused by enterovirus type 71. Korean J Pediatr (2011) 1.01
A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. Biomaterials (2011) 1.00
A mild and efficient method for the stereoselective formation of C-O bonds: palladium-catalyzed allylic etherification using zinc(II) alkoxides. Org Lett (2002) 1.00
Sec62 bridges the gap from 3q amplification to molecular cell biology in non-small cell lung cancer. Am J Pathol (2011) 0.99
Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease. Biol Blood Marrow Transplant (2007) 0.99
Polymethylmethacrylate-augmented screw fixation for stabilization of the osteoporotic spine : a three-year follow-up of 37 patients. J Korean Neurosurg Soc (2009) 0.99
Durability of bioprosthetic valves in the pulmonary position: long-term follow-up of 181 implants in patients with congenital heart disease. J Thorac Cardiovasc Surg (2011) 0.99
Comparison of Metabolic Characteristics of Metabolically Healthy but Obese (MHO) Middle-Aged Men According to Different Criteria. Korean J Fam Med (2013) 0.98
High levels of B cell activating factor during the peritransplantation period are associated with a reduced incidence of acute graft-versus-host disease following myeloablative allogeneic stem cell transplantation. Biol Blood Marrow Transplant (2009) 0.97
A novel function of interleukin-10 promoting self-renewal of hematopoietic stem cells. Stem Cells (2007) 0.96
Reduction of oxidative stress in cultured renal tubular cells and preventive effects on renal stone formation by the bioflavonoid quercetin. J Urol (2008) 0.96
Two cases of disseminated mucormycosis in patients following allogeneic bone marrow transplantation. J Korean Med Sci (2002) 0.95
Partial anomalous pulmonary venous connection to the superior vena cava: the outcome after the Warden procedure. Eur J Cardiothorac Surg (2011) 0.95
Mapping gene expression patterns during myeloid differentiation using the EML hematopoietic progenitor cell line. Exp Hematol (2002) 0.94
Conditional Akt activation promotes androgen-independent progression of prostate cancer. Carcinogenesis (2006) 0.93
B- to plasma-cell terminal differentiation entails oxidative stress and profound reshaping of the antioxidant responses. Antioxid Redox Signal (2010) 0.93
Stereoselective palladium-catalyzed O-glycosylation using glycals. J Am Chem Soc (2004) 0.93
Recurrent lymphadenopathy in children with Kikuchi-Fujimoto disease. Eur J Pediatr (2014) 0.93
Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome. Ann Hematol (2012) 0.92
A novel function of junctional adhesion molecule-C in mediating melanoma cell metastasis. Cancer Res (2011) 0.92
Impact of cytomegalovirus gastrointestinal disease on the clinical outcomes in patients with gastrointestinal graft-versus-host disease in the era of preemptive therapy. Ann Hematol (2012) 0.91
Frequency comb-based microwave transfer over fiber with 7×10(-19) instability using fiber-loop optical-microwave phase detectors. Opt Lett (2014) 0.91
TCR diversity of H60-specific CD8 T cells during the response evolution and influence of CD4 help. Transplantation (2009) 0.91
Clinical characteristics and antimicrobial susceptibilities of viridans streptococcal bacteremia during febrile neutropenia in patients with hematologic malignancies: a comparison between adults and children. BMC Infect Dis (2013) 0.91
Ruthenium-catalyzed carboxylative cyclization of 1,6-diynes. J Am Chem Soc (2007) 0.91
Ubiquitin ligase CHIP induces TRAF2 proteasomal degradation and NF-κB inactivation to regulate breast cancer cell invasion. J Cell Biochem (2011) 0.91
Effects of Pre-conditioning Dose on the Immune Kinetics and Cytokine Production in the Leukocytes Infiltrating GVHD Tissues after MHC-matched Transplantation. Immune Netw (2011) 0.90
Engagement of CD99 triggers the exocytic transport of ganglioside GM1 and the reorganization of actin cytoskeleton. FEBS Lett (2003) 0.90
Role of hepatocyte growth factor/c-Met signaling in regulating urokinase plasminogen activator on invasiveness in human hepatocellular carcinoma: a potential therapeutic target. Clin Exp Metastasis (2007) 0.89
Localizations and expressions of alpha-1A, alpha-1B and alpha-1D adrenoceptors in human ureter. Urol Res (2007) 0.89
T cell expression of CIITA represses Th1 immunity. Int Immunol (2004) 0.89
Clinically driven design of multi-scale cancer models: the ContraCancrum project paradigm. Interface Focus (2011) 0.89
A multicenter retrospective analysis of adverse events in Korean patients using bortezomib for multiple myeloma. Int J Hematol (2006) 0.89
The characteristics and clinical outcome of adult patients with aplastic anemia and abnormal cytogenetics at diagnosis. Genes Chromosomes Cancer (2010) 0.88
Prognosis of invasive pulmonary aspergillosis in patients with hematologic diseases in Korea. Tuberc Respir Dis (Seoul) (2012) 0.88
Outcomes of elderly de novo acute myeloid leukemia treated by a risk-adapted approach based on age, comorbidity, and performance status. Am J Hematol (2013) 0.88
PTEN modulates miR-21 processing via RNA-regulatory protein RNH1. PLoS One (2011) 0.88
A case of chronic myelomonocytic leukemia with severe eosinophilia having t(5;12)(q31;p13) with t(1;7)(q10;p10). Acta Haematol (2005) 0.88
Long-term pattern of pleural effusion from chronic myeloid leukemia patients in second-line dasatinib therapy. Int J Hematol (2011) 0.88